CLINICAL_TRIALS
trial_result
· 2021-01-13
Clinical Trial Update: Neoadjuvant BKM120 in High-risk Prostate Cancer [Phase 2]
Summary
A Phase 2 neoadjuvant trial evaluating BKM120 in high-risk prostate cancer was terminated; results were posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Won Kim | Conditions: High Risk Prostate Cancer | Phase 2 | Status: TERMINATED | Results posted: 2021-01-13